Pasinee Deeudomwongsa

Pasinee Deeudomwongsa

Auto-generated profile, based on publicly available information

Pasinee Deeudomwongsa

Institute of Dermatology Bangkok Thailand

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in Health Science Reports
Verified
Journal Article
Open access
CKChanisa Kiatsurayanon
Chanisa Kiatsurayanon
PDPasinee Deeudomwongsa
Pasinee Deeudomwongsa
PPPitcharat Pituvong
Pitcharat Pituvong
PSPraneet Sajjachareonpong
Praneet Sajjachareonpong
Background and Aims: Lichen planus pigmentosus (LPP) is an uncommon variant of lichen planus which most commonly affects middle‐aged individuals with skin of color. Despite multiple treatment modalities available for LPP, their efficacies are unpredictable and often disappointing. In this study, we aimed to investigate the use of platelet‐rich plasma (PRP) as a novel therapy for LPP.Methods: Twelve patients received three sessions of intradermal PRP injection at a 2‐week interval. Week 0, 2 and 4 were treatment sessions, while Week 6, 8 and 12 were follow‐up visits. Mean melanin index (MI), physician global assessment (PGA) and clinical photographs were assessed at Week 0, 2, 4, 6, 8, and 12, while quartile grading scale (QGS) and patient satisfaction were evaluated at Week 2, 4, 6, 8, and 12. Adverse effects were also recorded.Results: Initial mean MI was 448.19 (18.76) and declined to 409.64 (19.13) at week 12 (p = 0.045). Clinical improvement as evidenced by an increase in mean QGS from Week 2 to Week 12, and a reduction on average PGA score from 3.04 at baseline to 2.21 at Week 6, 2.04 at Week 8, and 2.23 at Week 12, was observed. At Week 12, 5 patients (41.67%) reported more than 50% improvement of LPP lesions.The adverse effects were minimal, consisting primarily of swelling and bruising, which resolved on their own within a few days without the need for treatment.Conclusion: We report the first pilot study utilizing PRP for LPP treatment. The pilot study indicated that PRP significantly improved facial LPP lesions with no significant side effects. Further well‐designed studies with a larger sample size, longer follow‐up duration and possible longer treatment times are necessary to confirm this preliminary observation.Trial Registration: Thai Clinical Trials Registry identification number: TCTR20230202004 (https://www.thaiclinicaltrials.org/show/TCTR20230202004) approved on 02 February 2023.

13 December 2023 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDPasinee Deeudomwongsa
Pasinee Deeudomwongsa
CCChumsaeng Chumsaengsri
Chumsaeng Chumsaengsri
MAMiguel Aristizabal
Miguel Aristizabal
CKChanisa Kiatsurayanon
Chanisa Kiatsurayanon
Background: Hori's nevus is a common and challenging dermatological condition, often complicated by post‐inflammatory hyperpigmentation following treatment. Platelet‐rich plasma (PRP) has demonstrated efficacy in the treatment of hyperpigmentation disorders such as melasma and periorbital darkening. Given the benefits and minimally invasive nature of PRP treatments, exploring its application in managing Hori's nevus through further investigation is worthwhile. Aims: To evaluate the safety and effectiveness of intradermal PRP therapy for the treatment of Hori's nevus. Methods: Ten female patients received bilateral intradermal PRP injections every 2 weeks for a total of four treatments. The modified dermal pigmentation and severity index (mDPASI), mean melanin index (MI), brightening score, patient self‐assessment, and clinical photographs were evaluated at 2, 4, 8, and 12 weeks post‐treatment. Adverse events were also recorded to determine treatment safety. Results: At 12 weeks post‐treatment, mDPASI decreased 38.86%, from 0.929 ± 0.617 to 0.568 ± 0.415 ( p < 0.05). The mean melanin index decreased 12.75%, from 208.650 ± 26.319 to 182.052 ± 17.028 ( p < 0.05). In addition, the mean brightness score evaluated by two experts was 1.4, indicating 25–50% improvement. At the end of the study, 50% of the patients reported 50–75% improvement. Side effects included pain, mild edema, and bruising, which resolved spontaneously within 3 days. No serious side effects were found. Conclusion: Our results suggest that intradermal PRP therapy may be a safe and effective alternative for the treatment of Hori's nevus and can complement conventional interventions. However, further research with a larger sample size, control groups, and longer follow‐up is needed to confirm these findings.